Thermo Fisher produce reliable COVID-19 testing kits in Bengaluru

Thermo Fisher to produce reliable COVID-19 testing kits in Bengaluru

7:47 AM, 18th February 2021
Thermo-Fisher-Scientific
A new state-of-the-art Thermo Fisher Scientific manufacturing facility in Bengaluru will produce COVID-19 testing kits and diagnostic solutions that are made in India for use in India

BENGALURU, INDIA: A new state-of-the-art Thermo Fisher Scientific manufacturing facility in Bengaluru will produce COVID-19 testing kits and diagnostic solutions that are made in India for use in India.

CoviPath COVID-19 RT-PCR Kit, which contains the assays and controls for Thermo Fisher’s gold standard RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in individuals suspected of COVID-19.

The CoviPath COVID-19 RT-PCR Kit has been approved under MDR 2017 rules for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and Drug Control General of India (DCGI) in all authorized laboratories. Testing with the kit can be done on Applied Biosystems real-time PCR instruments with FAM dye, VIC dye, and JUN dye or any RT-PCR platform with 3 dye channels in molecular biology laboratories approved for testing. Samples are collected from nasopharyngeal swab, nasopharyngeal aspirate and bronchoalveolar lavage (BAL) specimens.

“Thermo Fisher has been playing a central role in the fight against COVID-19 pandemic. The introduction of this kit and the new facility strengthens our commitment towards the COVID-19 response in India.The new facility is equipped with the capacity to manufacture up to 10 million tests every month. This facility will be instrumental in ensuring access to affordable testing kits while maintaining global quality standards,” said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific.

The CoviPath COVID-19 RT-PCR Kit is designed to detect viral targets with low mutations and offers more than 99.5 percent sensitivity and 99.5 percent specificity. The kit is packaged in a user- friendly and convenient pack size of 200 reactions. The company will make these kits available across the country leveraging its strong distribution network.

“As the country is racing to normalcy, it is imperative to have reliable, affordable and quick-to deliver testing kits. Thermo Fisher’s local production facility will augment accessibility of testing kits across the country. We are thankful to all our stakeholders and customers in extending their support,” said Kapil Sood, senior director, life sciences solutions, Thermo Fisher Scientific, India.The Applied Biosystems CoviPath COVID-19 RT-PCR Kit is for use in India only.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Aral, bps fuel retail brand accelerates ultra-fast charging expansion

BOCHUM, GERMANY: Aral, bp's market leading fuel retail brand in Germany, is expanding its ‎charging network of ultra-fast electric charging statio ...

Read more
Lightsource bp secure a new 845MW pipeline in Spain

MADRID, SPAIN: Lightsource bp, a global leader in the development andmanagement of solar energy projects, has announced the acquisition of an 845 mega ...

Read more
Sika acquires mortar manufacturer in Russia

BAAR, SWITZERLAND: Sika has agreed to acquire Kreps LLC, a leading mortar manufacturer in Russia. The company offers a wide range of mortar products f ...

Read more
AkzoNobel no longer intends to acquire Tikkurila

AMSTERDAM, THE NETHERLANDS: AkzoNobel NV submitted a binding proposal to acquire Tikkurila for €31.25 per share on January 28, 2021, having condu ...

Read more
BASF opens Isobionics' new distillation plant in Netherlands

GELEEN, NETHERLANDS: Toine Janssen, CEO of Isobionics® formally opened the new Isobionics distillation plant at Brightlands Chemelot Campus in Gel ...

Read more
Total, GIG to jointly develop 1.5 GW offshore wind project in UK

PARIS, FRANCE: A 50/50 joint venture between Macquarie’s Green Investment Group (GIG) and Total has been successful in securing rights to a seab ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X